Optimal strategies for the diagnosis of acute pulmonary embolism: A health technology assessment
The objective of this health technology assessment (HTA) is to assess the optimal diagnostic strategy for acute pulmonary embolism (PE) in urban, rural, and remote settings through an assessment of the diagnostic test accuracy, clinical utility, safety, cost-effectiveness, patients' perspective...
| Main Author: | |
|---|---|
| Corporate Author: | |
| Format: | eBook |
| Language: | English |
| Published: |
Ottawa (ON)
Canadian Agency for Drugs and Technologies in Health
2018, January 2018
|
| Series: | CADTH optimal use report
|
| Subjects: | |
| Online Access: | |
| Collection: | National Center for Biotechnology Information - Collection details see MPG.ReNa |
| Summary: | The objective of this health technology assessment (HTA) is to assess the optimal diagnostic strategy for acute pulmonary embolism (PE) in urban, rural, and remote settings through an assessment of the diagnostic test accuracy, clinical utility, safety, cost-effectiveness, patients' perspectives and experience, implementation issues, and the environmental impact of strategies for the diagnosis of adults with suspected PE. |
|---|---|
| Item Description: | "PROSPERO Registration Number: 42016046980." |
| Physical Description: | 1 PDF file (413 pages) illustrations |